Chilli RF Ablation System Approval Broader Than Recommended By Panel
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Pathways Corporation's Chilli cooled ablation system, approved via premarket approval application Feb. 2, has received a much less restrictive indication from FDA than recommended by the agency's Circulatory System Devices Advisory Panel.